Such Birinapant-induced, endogenous TNFα- and TRAIL-dependent cell death has already been described for different tumor cells, among them also for triple negative breast cancer cells (TNBC) (Petersen et al., 2007; Varfolomeev et al., 2007; Lalaoui et al., 2020). This evidence concerns the gene TNFSF10 and neoplasm.